Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® Extend

Completed · Phase 1

Conditions studied: Healthy Subjects

In brief

This study will evaluate the pharmacokinetic profiles of experimental formulations of paracetamol.

Key facts

Study ID

NCT01540721

Run by

GlaxoSmithKline

People needed

28

Starts

2009-12-01

Expected to finish

2009-12-01

Last updated by the study team

2014-11-24

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Good health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history or physical examination

You may not qualify if…

• Current (within 14 days of screening) or regular use of any prescription, over the counter (OTC) drugs including paracetamol/acetaminophen, herbal medicine or drug known to induce or inhibit hepatic drug metabolism, excluding prescription birth control, if applicable.

Where it is running

• MDS Pharma Services NEBRASKA — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.